Report of a newly indentified patient with mutations in BMP1 and underlying pathogenetic aspects

Osteogenesis imperfecta is a genetic condition characterized by bone fragility and recurrent fractures, which in the large majority of patients are caused by defects in the production of type I collagen. Mutations in the gene encoding bone morphogenetic protein 1 (BMP1, also known as procollagen C-e...

Full description

Bibliographic Details
Main Authors: Valencia, M., Caparrós-Martín, Jose, Sirerol-Piquer, M., García-Verdugo, J., Martínez-Glez, V., Lapunzina, P., Temtamy, S., Aglan, M., Lund, A., Nikkels, P., Ruiz-Perez, V., Ostergaard, E.
Format: Journal Article
Published: John Wiley & Sons, Inc. 2014
Online Access:http://hdl.handle.net/20.500.11937/68226
Description
Summary:Osteogenesis imperfecta is a genetic condition characterized by bone fragility and recurrent fractures, which in the large majority of patients are caused by defects in the production of type I collagen. Mutations in the gene encoding bone morphogenetic protein 1 (BMP1, also known as procollagen C-endopeptidase) have been associated with osteogenesis imperfecta in two sib pairs. In this report, we describe an additional patient with osteogenesis imperfecta with normal bone density and a recurrent, homozygous c.34G > C mutation in BMP1. Western blot analysis of dermal fibroblasts from this patient showed decreased protein levels of the two alternatively spliced products of BMP1 and abnormal cleavage of the C-terminal propeptide of type I procollagen. In addition, fluorescence and electron microscopy showed impaired assembly of type I collagen fibrils in the extracellular matrix of cultured fibroblasts derived from two patients: the patient described here and a previously reported patient with a homozygous BMP1 c.747C > G mutation. We conclude that BMP1 is essential for human type I collagen fibrilogenesis. © 2014 Wiley Periodicals, Inc.